Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the long-term safety, tolerability and efficacy
of neramexane mesylate in the treatment of congenital idiopathic nystagmus (CIN). In
addition, a subgroup of multiple sclerosis (MS) patients suffering from acquired nystagmus
will be included.